Prospective oral mucositis audit oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European "Blood" and Marrow Transplantation Mucositis Advisory Group

AllImages Books Videos Maps News Shopping

Past year

All results

All results
Verbatim

[PDF] The oral cavity as a source of febrile neutropenia - NVMKA

www.nvmka.nl › uploads › Proefschrift-J.A.E.M.-Zecha-.pdf

Nov 1, 2024 � receiving high-dose melphalan or BEAM conditioning chemotherapy--European. Blood and Marrow Transplantation Mucositis Advisory Group. J Clin Oncol, 2008. 26�...

[PDF] Evaluation of the Incidence and Stage of Oral Mucositis in Patients ...

fnjn.org › Content › files › sayilar › FNJN_October_2024-261-268

Oct 31, 2024 � Salivary microbial and metabolic determinants of oral mucositis in recipients of allogeneic hematopoietic stem cell trans- plantation. Biology of Blood and�...

Ann Roosaar | Karolinska Institutet

ki.se › personer › ann-roosaar

Dec 18, 2023 � ... patients receiving high-dose ... dose melphalan or BEAM conditioning chemotherapy - European blood and marrow transplantation mucositis advisory group.

Prevalence and risk factors of chemotherapy‐induced oral mucositis ...

onlinelibrary.wiley.com › doi › abs › ajco

Dec 26, 2023 � The effects of oral hygiene on mucositis in patients undergoing hematopoietic stem cell transplant (HSCT). Biol Blood Marrow Transplant. 2017; 23(3): S475�...

Preconditioning with Photobiomodulation as an Effective Method in ...

www.liebertpub.com › doi › abs › photob.2023.0075

Dec 15, 2023 � ... mucositis in patients receiving high-dose ... melphalan or BEAM conditioning chemotherapy—European Blood and Marrow Transplantation Mucositis Advisory Group.

Pam Bacon – Schweiz | Berufliches Profil - LinkedIn

ch.linkedin.com › pambacon

Oct 15, 2024 � Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow�...

Dr. Rebecca L. Stone, MD | Baltimore, MD - US News Health

health.usnews.com › Doctors

Nov 18, 2024 � ... Mucositis in Patients Receiving High-Dose Melphalan or BEAM Conditioning Chemotherapy—European Blood and Marrow Transplantation Mucositis Advisory Group.

(PDF) Clinical audit - A literature review - ResearchGate

www.researchgate.net › publication › 289224065_Clinical_audit_-_A_liter...

Oct 22, 2024 � ... Oral. mucositis in patients receiving high-dose melphalan or BEAM. conditioning chemotherapy-European blood and marrow. transplantation mucositis advisory group�...

[PDF] The EBMT Handbook

www.ebmt.org › sites › default › files

Apr 30, 2024 � In 94 chapters, all types of hema- topoietic cell and bone marrow transplantation including haplo-identical and cord blood transplantation, indication for�...

TEAM Conditioning (Thiotepa, Etoposide, Cytarabine, Melphalan ...

www.researchgate.net › ... › Neuroscience › Central Nervous System

Nov 12, 2024 � The effect of ATL-104 on mucositis in patients requiring high-dose melphalan or BEAM before peripheral blood SCT (PBSCT) was investigated in a randomized,�...